What is the prevalence of uterine (endometrial) polyps in a 32‑year‑old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prevalence of Uterine Polyps in 32-Year-Olds

Endometrial polyps are uncommon in 32-year-old women, with an estimated prevalence of approximately 1-6% in this age group, based on the best available population data showing polyps are rare (0.9%) in women under 30 years and increase progressively with age.

Age-Specific Prevalence Data

The most robust population-based study examining endometrial polyp prevalence across age groups found that polyps are distinctly rare in younger women 1. Specifically:

  • Women under 30 years: 0.9% prevalence
  • Premenopausal women overall: 5.8% prevalence
  • Postmenopausal women: 11.8% prevalence
  • Overall population (ages 20-74): 7.8% prevalence

At age 32, you fall into the younger premenopausal category where polyp prevalence remains low, likely in the 1-6% range based on the age-related gradient demonstrated in the Danish population study 1.

Key Clinical Context

The vast majority (82%) of women with histologically confirmed endometrial polyps are asymptomatic 1. This is a critical point—most polyps don't cause symptoms, and interestingly, abnormal uterine bleeding was actually more frequent in women without polyps (38%) than in those with polyps in the population study.

Risk Factors That Increase Prevalence

Even at age 32, certain conditions significantly elevate polyp risk:

  • Endometriosis: Women with endometriosis have a 2.18-fold increased risk of endometrial polyps 2
  • Obesity: Higher BMI independently increases polyp risk 3, 4
  • Hormonal therapy use: Oral contraceptive users had 2% prevalence while hormone therapy users had 25% prevalence 1
  • Nulliparity: Associated with increased polyp risk 4

Clinical Implications for a 32-Year-Old

If asymptomatic: The likelihood of having an endometrial polyp is very low (approximately 1-6%), and routine screening is not indicated 5.

If symptomatic with abnormal bleeding: Transvaginal ultrasound is the first-line imaging modality 6. However, normal endometrial thickness does not exclude polyps in premenopausal women, as polyps can be present even with endometrial thickness <5 mm 6.

Malignancy risk at this age: Extremely low. In the population study, premalignant/malignant lesions were found in only 1.89% of all polyps detected, predominantly in older women 3.

Diagnostic Approach When Polyps Are Suspected

If initial transvaginal ultrasound shows a focal endometrial abnormality, saline contrast sonohysterography can distinguish polyps from submucosal leiomyomas with 97% accuracy 6. Sonohysterographic features favoring a polyp include:

  • Intact myometrial-endometrial interface
  • Single feeding vessel
  • Acute angle with endometrium
  • Homogeneous echogenicity 6

Important caveat: Neither ultrasound nor sonohysterography can reliably distinguish benign from malignant endometrial pathology, though malignancy is exceptionally rare at age 32 6.

References

Research

Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2009

Research

Guideline No. 447: Diagnosis and Management of Endometrial Polyps.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2024

Guideline

acr appropriateness criteria® abnormal uterine bleeding.

Journal of the American College of Radiology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.